Skip to main
ANCN
ANCN logo

Anchiano Therapeutics Ltd - ADR (ANCN)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ANCN Stock

About Anchiano Therapeutics Ltd - ADR (ANCN)

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
Market cap$15.2M
Today's volume14.77K
Revenue (TTM)
Avg. daily volume153.77K
EBITDA (TTM)
Open$2.49
Price / earnings ratio-1.33x
Today's range$2.5 - $2.62
Debt / equity
52 week range$2.36 - $9.84
5 year debt / equity0.9x
Beta (LTM)0.93x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio10.49x
Ex-dividend date
Next earningsMar 9, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for ANCN stock is $15.21M

The current P/E ratio for ANCN stock is -1.33

The 52-week high for ANCN stock is $9.84. The current ANCN stock price $undefined is 100.00% below its 52-week high

The 52-week low for ANCN stock is $2.36. The current ANCN stock price $undefined has increased 100.00% from its 52-week low

No, the ANCN stock does not pay dividends to its shareholders

How to buy ANCN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ANCN stock

    Navigate to the Explore page. Then, type ANCN into the search bar. When you see ANCN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ANCN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Anchiano Therapeutics Ltd - ADR Stock Earnings

The value each ANCN share was expected to gain vs. the value that each ANCN share actually gained.

ANCN (ANCN) reported Q1 2020 earnings per share (EPS) of -$0.10, beating estimates of -$0.11 by 9.09%. In the same quarter last year, ANCN's earnings per share (EPS) was $0. ANCN is expected to release next earnings on 03/09/2021, with an earnings per share (EPS) estimate of $0.

Buy ANCN Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.